We serve Chemical Name:Oxalic acid dihydrate CAS:6153-56-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Oxalic acid dihydrate
CAS.NO:6153-56-6
Synonyms:MFCD00149102;oxalic acid,dihydrate;EINECS 205-634-3
Molecular Formula:C2H6O6
Molecular Weight:126.065
HS Code:29171100
Physical and Chemical Properties:
Melting point:104-106 °C(lit.)
Boiling point:108-109°C
Density:1,65 g/cm3
Index of Refraction:
PSA:93.06000
Exact Mass:126.016441
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3261 8/PG 3
Packing Group:III
Contact us for information like MFCD00149102 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 205-634-3 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 205-634-3 Use and application,MFCD00149102 technical grade,usp/ep/jp grade.
Related News: The API is not made by only one reaction from the raw materials but rather it becomes an API via several chemical compounds. Oxalic acid dihydrate manufacturer The two trials studied similar patient populations, Tendler said, but VMP was an old standard of care that’s not really used today in the U.S. Still, Tendler believes the two regimens may both have roles to play based on each patient’s ability to tolerate them. Whichever cocktail physicians choose, the two phase 3 studies have confirmed the benefit of Darzalex in transplant-ineligible patients, he added. Oxalic acid dihydrate supplier Take penicillin industrial salt and vitamin C as examples. They are the two strategic varieties of chemical raw materials in China, and they are also representatives of severe overcapacity. Oxalic acid dihydrate vendor The API is not made by only one reaction from the raw materials but rather it becomes an API via several chemical compounds. Oxalic acid dihydrate factory The two trials studied similar patient populations, Tendler said, but VMP was an old standard of care that’s not really used today in the U.S. Still, Tendler believes the two regimens may both have roles to play based on each patient’s ability to tolerate them. Whichever cocktail physicians choose, the two phase 3 studies have confirmed the benefit of Darzalex in transplant-ineligible patients, he added.